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71. Live imaging of stroke induced neurogenesis in the mouse brain
T.D. Farr1, T. Kallur1, D. Wiedermann1, S. Couillard-Despre´s2, L. Aigner2 and M. Hoehn1
1In vivo NMR Laboratory, Max-Planck Institute for Neurological Research, Cologne; 2Department of
Neurology, University of Regensburg, Regensburg, Germany
Background and aims: Neurogenesis is upregulated
following stroke, and may contribute to brain repair.
Neurogenesis is typically studied invasively. Recently,
transgenic mice were generated that express either
Discoma sp reef coral red fluorescent protein (DsRed)
(Couillard-Despre´s et al. Eur J Neurosci 2006;24:
1535–45), or the bioluminescent enzyme luciferase
(LUC) (Couillard-Despre´s et al. Mol Imaging 2008;
7:28–34), under the control of the migrating neuro-
blast promoter doublecortin (DCX). Therefore, the
aims of this project were to employ noninvasive
multimodal imaging to observe the timecourse and
expression patterns of the neurogenic response fol-
lowing focal ischemia, in vivo.
Methods: Male CD1 DCX-LUC mice (37 to 44 g)
(n= 4) and C57/BL6 DCX-DsRed mice (29 to 35 g)
(n= 3) received different durations (30, 20, or
10 mins) of transient middle cerebral artery occlu-
sion (MCAO); one DsRed mouse received a sham
procedure. Optical imaging was performed to detect
fluorescence, or bioluminescence (using intraperito-
neal administration of 150 mg/kg of luciferin), at 23
days prior to and 12 days post MCAO. Anatomical
magnetic resonance imaging (MRI) scans (spin echo
T2-weighted, and 3D fast low angle shot (FLASH)
images) were acquired 4 days prior to and 7 days
post-MCAO at 11.7 T. Two DsRed mice (including
the sham) were sacrificed at 7 days post-MCAO and
the other animals at 12 days. Brain tissue was
processed for fluorescent immunohistochemistry
for the imaging reporters in combination with DCX
and GFAP.
Results: Ischemia durations of 30 mins produced
extensive lesions and mortality, as observed from T2
maps, whereas smaller subcortical insults were
produced using 10 to 20 mins of occlusion. No
fluorescent signal was detected from the C57/BL6
DCX-DsRed animals in vivo, but photons produced
from the oxidation of luciferin in the CD1 DCX-LUC
mice were observed and counted. Emission was
highest in the head in a pattern similar to the
pathway of the rostral migratory stream in the brain
(Figure 1C and D). Following MCAO the biolumi-
nescent signal increased and appeared to shift
laterally towards the injured hemisphere (Figure 1E
and F). Improved localization will be possible using
co-registration of the optical images to the FLASH 3D
MRI data set (Figure 1A and B).
Conclusions: These preliminary results indicate that
monitoring the neurogenic response in vivo follow-
Figure 1 (A and B): Horizontal and sagital FLASH images from a CD1 DCX-LUC animal at 4-days prior to mcao, (C and D): Corres-
ponding bioluminescent images (counts/minute per cm2) from the same animal 23 days prior to and 12 days post MCAO (E and F).
Note the increase in bioluminescence after MCAO, and shift towards the ischemic hemisphere.
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ing stroke is possible. Ongoing work is being
performed to characterize the location, intensity,
and timecourse of this response using a multimodal
imaging protocol combined with histological validation.
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235. Brain plasticity and anti-depressant effects are versatile potential of
alpha-linolenic acid to promote stroke recovery
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Objectives: Prevention and treatment of stroke, a
major public Health concern in Western countries,
are major challenges in modern medicine. Besides
mortality and devastating neurovascular unit da-
mages, post-stroke depression (PSD) is a frequent
psychiatric complication (prevalence of 30%). PSD
increases mortality rates and worsen functional
outcomes. We have previously demonstrated that
alpha-linolenic acid (ALA), a polyunsaturated fatty
acid reduces the ischemic damage by limiting
glutamate-mediated neuronal death. We aimed to
create a global strategy based on three sequential
injections of ALA for stimulating brain responses
and decreasing the post-stroke psychiatric complica-
tions to achieve the best functional recovery.
Methods:
(1) The protective effects of three sequential injec-
tions of ALA as pre- or post-treatment against
stroke were determined using the MCAO model
in mice.
(2) The effect of single or repeated ALA-injection
treatment on neurogenesis was evaluated study-
ing BrdU incorporation in the hippocampal
Dentate Gyrus and by immunohistochemistry
with fluorescent double-labeling.
(3) Neuronal plasticity known to contribute to brain
repair was evaluated measuring the expression of
key proteins involved in synaptic functions,
synaptophysin-1, VAMP-2, and SNAP-25 as well
as proteins supporting glutamatergic neurotrans-
mission, V-GLUT1 and V-GLU2, by Western blot.
(4) To investigate the functional-anatomical relation-
ship between ALA and neurogenesis/synaptogen-
esis, we studied BDNF expression by RT-PCR,
Western blot and ELISA.
(5) Neuroprotection, neurogenesis and synaptogen-
esis were also tested in vitro on neural stem cells
and hippocampal cultures.
(6) ALA treatment was tested in the Porsolt Forced
Swim Test and Tail Suspension Test, that are
commonly accepted to predict antidepressant
efficiency of drugs.
Results: Three sequential injections of ALA en-
hanced protection. As a pre-treatment, it reduced
by approximately 30% the post-ischemic infarct
volume 24 h post-MCAO. As post-treatment, it
augmented neuronal survival rates by three-fold
10 days following ischemia. By themselves the three
sequential injections of ALA increased neurogenesis
3 days after the end of the treatment. BrdU-positive
cells increased by 1.5 in the ALA-injected mice as
well as the number of neuronal progenitor cells
Brdu-DCX positive by 50%. In the cortex, ALA
treatment induced a parallel increase of synaptophy-
sin-1 and VAMP-2, two vesicle-associated synaptic
proteins and SNAP-25, their membrane-associated
synaptic protein. It also increased the vesicular
glutamate transporters V-GLUT-1 and -2 (key factors
of the glutamatergic neurotransmission efficacy).
These ALA effects were correlated with an in vivo
increase in BDNF protein levels, which was con-
firmed in vitro on neural stem cells and hippocampal
cultures. Because BDNF has antidepressant activity,
we tested whether chronic ALA treatment could
produce antidepressant-like behavior. ALA-injected
mice had significantly reduced measures of depres-
sive-like behavior compared to vehicle-treated ani-
mals, suggesting another aspect of ALA treatment
that could boost functional stroke recovery by
reducing psychiatric complication.
Conclusion: The present work demonstrates that
treatment of experimental stroke with repeated
ALA-injections improves protection. Beside to acute
vasodilation and excitotoxicity limitation ALA
displays versatile potential like enhancement of
neurogenesis, synaptogenesis and neurotransmitter
transmission. From a clinical point of view, this
‘multi-target’ effect of chronic ALA-treatment may
represent a novel approach to stroke and subsequent
PSD therapies.
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376. Neurogenesis of motor neurons in the spinal cord after transient ischemia
G. Takahashi1, M. Sakurai2 and K. Tabayashi1
1Cardiovascular Surgery, Tohoku University Graduate School of Medicine; 2Cardiovascular Surgery,
Sendai Medical Center, Sendai, Japan
Objectives: Spinal cord injury after a successful
operation on the thoracic aorta is a disastrous and
unpredictable complication in humane beings. In an
attempt to prevent this complication, various meth-
ods of spinal cord protection have been suggested,
Because motor neurons in spinal cords have been
thought not to replace after cell deaths. It has already
shown that self-renewing stem cells do exist in
discrete brain regions, including the dentate gyrus
(DG) of the hippocampus and subependymal layer
close to the subventricular zone (SVZ) of lateral
ventricles. Recent studies have shown that adult
neurogenesis is increased by an exogeneous neuro-
trophic factor supplement, seizures kindling an
enriched environment and transient global ischemia,
and is decreased by stress, excitatory amino acids,
and adrenal steroids. On the other hand, motor
neurons in anterior horns of spinal cord after
transient ischemia has been thought to die with
apoptotic change,1 and do not replaced after cell
death. In the spinal cord, neurogenesis cannot be
observed under physiologic condition. However, a
different situation occurs after pathological spinal
cord injury.2
Because ischemic stroke often causes loss of
the neural functions because of neural cell death,
neurogenesis after ischemia should be important for
compensation for and recovery of those functions.
The stage of neurogenesis in the DG can be divided
into three steps; (1) proliferation, (2) migration,
(3) differantiation.3
In the present study, we evaluate the three steps of
neurogenesis in spinal cord after transient ischemia.
Materials and methods: Male domesticated white
rabbits (Japan) were subjected to reproducible
models for spinal cord ischemia. To evaluate the
three steps of neurogenesis after ischemia, we used
bromodeoxiuridine (BrdU), highly polysialylated
neural cell adhesion molecule (PSA-NCAM), and
neural molecular antigen (NeuN), and glial fibrillary
acidic protein (GFAP), as markers for proliferation,
migration, and differentiation, respectively.
Results: BrdU-labelled cells and PSA-NCAM-posi-
tive cells increased in the anterior horns of spinal
cord at four days after ischemia. BrdU-labelled cells
with PSA-NCAM expression were first detected in
the spinal cord after 4 days of transient ischemia.
A few of PSA-NCAM labeled cells with NeuN
was detected after 7 days, however no PSA-NCAM-
labelled with GFAP was detected.
Conclusions: Our results indicate that ischemic stress
could stimulate the ability of neurogenesis even in
spinal cord. Our findings will be important in
developing therapeutic intervention to enhance endo-
genious neurogenesis after spinal cord ischemia.
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381. Changes in cell death, gliosis and cell proliferation/differentiation in the
amygdala following myocardial infarction
S.S. Yi1, I.K. Hwang1, K.-Y. Yoo2, T.H. Han3, C.H. Lee2, S.Y. Lee3, P.D. Ryu3, M.-H. Won2
and Y.S. Yoon1
1Department of Anatomy and Cell Biology, College of Veterinary Medicine, Seoul National University, Seoul;
2Department of Anatomy and Neurobiology, College of Medicine, Hallym University, Chuncheon; 3Laboratory
of Veterinary Pharmacology, College of Veterinary Medicine, Seoul National University, Seoul, South Korea
Background and aims: Myocardial infarction (MI),
also known as a heart attack, occurs when the
blood supply to the heart is interrupted and finally
this cause damage to myocardium. Recent studies
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showed that depression is frequently observed follow-
ing MI, suggesting a link between heart disease and
brain function. It has been reported that the neuronal
death are occurred in the amygdala 72 h after 40 mins
coronary artery occlusion. The amygdala is a central
component of the limbic system and plays a crucial
role in behavioral responses to emotional stress.in
recent study, new neurons are produced in the
amygdala, piriform cortex, and adjoining inferior
temporal cortex in adult primates. Although some
researchers have demonstrated the neuronal death in
the amygdala after MI, no studies have been reported
on cell proliferation/differentiation and gliosis in the
amygdala after MI in rats.
Methods: Induction of MI, Cresyl violet staining,
Fluoro-Jade B (F-J B) histofluorescence staining and
Immunohistochemistry for GFAP, Iba-1, Ki67 and DCX.
Purpose: In this study, we examined cell prolifera-
tion and neuroblast differentiation in the amyg-
dala and morphological changes in astrocytes and
microglia 2 weeks after MI, when behavioral signs
compatible with depression are detected after cardio-
vascular events.
Results: In MI-operated group, cresyl violet positive
neurons had condensed cytoplasm and Fluoro-Jade
B-positive cells were detected. The cytoplasm of glial
fibrillary acidic protein (GFAP) immunoreactive
astrocytes and ionized calcium-binding adapter
molecule 1 (Iba-1) immunoreactive microglia were
hypertrophied and the processes in astrocytes and
microglia were highly ramified and retracted in the
amygdala. The number of Ki67 positive cells was
significantly increased by 815% in MI-operated
group compared to that in the sham-operated group.
In addition, DCX immunoreactive neuroblast were
abundant in the amygdala of MI-operated group.
Conclusions: The neuronal death, reactive gliosis
and cell proliferation is promiment 2 weeks after MI.
However, the neuronal differentiation is not detected
this region. These results suggest that MI induce
neuronal damage, reactive gliosis and proliferation of
glia and neurons.
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388. A role of phosphorylation of CREB for neural progenitor cells in the SVZ
and peri-infarct area
Y. Tanaka, N. Miyamoto, R. Tanaka, N. Hattori and T. Urabe
Neurology, Juntendo University School of Medicine, Tokyo, Japan
Background and purpose: We noted that transcription
factor phosphorylation of cAMP response element-
binding protein (CREB) is associated with a proliferation
of neural progenitor cells (NPC) in the subventricular
zone (SVZ) after ischemia. We examined whether acute
focal ischemia induces neurogenesis and the expression
of phosphorylation of CREB in the ischemic area.
Methods: Middle cerebral artery occlusion (MCAO) was
administered to mice by filament insertion for 45mins
and sacrificed at 24h, 72h and 7day after ischemia. 5-
bromo-2-deoxyuridine (BrdU) was used to label prolif-
erating cells and immunohistochemistry was performed.
Results: The numbers of BrdU/doublecortin (DCX)
in the SVZ and the peri-infarct area significantly
increased than contralateral side at 72 h (P< 0.05).
Phospho-CREB/DCX double-labeled cells also in-
creased in the SVZ at 72 h (P< 0.05). However,
a small numbers of phospho-CREB/DCX double-
labeled cells were seen from 72 h to 7day in the
peri-infarct area.
Conclusions: Our result showed that phosphoryla-
tion of CREB might play an important role in survival
of newly generated NPCs in the SVZ and peri-
ischemic area after MCAO.
399. RNAI-mediated downregulation of Beclin1 attenuates focal cerebral
ischemic injury and enhances neurogenesis in rats
Y.-Q. Zheng, J.-X. Liu and X.-Z. Li
Research Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China
Objectives: Because autophagy appears to be occurring
after cerebral ischemia, we tested the roles of Beclin
1-dependent autophagic way in focal cerebral ischemia in
the rat middle cerebral artery occlusion model (MCAO).
Brain poster session: neurogenesis
S547
Journal of Cerebral Blood Flow & Metabolism (2009) 29, S544–S552
Methods: Lentiviral vectors-associated RNA interfer-
ence (RNAi) system was stereotaxically injected into
the ipsilateral lateral ventricle to reduce Beclin1
expression. We than evaluated the ipsilateral infarct
volume, autophagosomes formation, neurogenesis and
apoptosis which might be modulated by Beclin1 RNAi.
Results: Beclin1 RNAi not only inhibited the auto-
phagosomes formation but also repaired the ischemic
injury in the ipsilateral hemisphere. On the 14th day
after MCAO, Beclin-1 downregulation by RNAi in-
creased the number of neural progenitor cells, new-
born immature and mature neurons and reduced
the apoptosis of immature striatal neurons in the
surrounding ischemic core of ipsilateral hemisphere.
Conclusions: RNAi-mediated downregulation of Be-
clin1 improves outcomes after transient MCAO. This
neuroprotective effect is likely exerted by inhibiting
autophagy and apoptosis and enhancing neurogenesis.
502. Modulation of fate determinants Olig2 and Pax6 in resident Glia evokes
spiking neurons receiving synaptic input after mild brain ischemia
K. Gertz1, G. Kronenberg1, G. Cheung2, A. Buffo3, H. Kettenmann2, M. Go¨tz3 and M. Endres1
1Experimental Neurology, Charite´—University Medicine Berlin; 2Max Delbru¨ck Center for Molecular
Medicine, Berlin; 3Institute for Stem Cell Research, Helmholtz-Center, Munich, Germany
Background: Although in vitro studies suggest that
non-neurogenic regions of the adult central nervous
system potentially contain multipotent parenchymal
progenitors, neurons are clearly not replaced in most
brain regions after injury. The transcription factors
Olig2 and Pax6 play largely opposing roles in deter-
mining progenitor cell fate in neurosphere culture as
well as in the adult mammalian central nervous system
in vivo. We have previously demonstrated that after
cerebral ischemia astrocytes expressing enhanced green
fluorescent protein (eGFP) under control of the GFAP
promoter predominantly adopt a complex electro-
physiological phenotype. Importantly, the majority of
GFAPeGFP + cells are also Olig2-immunoreactive.
Therefore, we here explored Olig2 antagonism and
Pax6 overexpression in a model of mild transient brain
ischemia to re-direct endogenous resident progenitors
proliferating in situ toward a neuronal fate.
Methods: 129/Sv wildtype mice were subjected to
30 mins of filamentous middle cerebral artery occlu-
sion (MCAo) followed by reperfusion. 48 h later,
retroviruses containing either only GFP, Olig2-
VP16-IRES-GFP to interfere with Olig2 function, or
Pax6-IRES-GFP were injected stereotaxically into the
ischemic lesion core, i.e. the lateral striatum. Animals
were killed at 10 and 17 days after MCAo for further
immunohistological and electrophysiological analysis.
Results: Cells transduced with the control vector
showed complex glial membrane properties and did
not express Doublecortin (DCX). By contrast, DCX +
cells emerged reproducibly both after repression of
Olig2 and after overexpression of Pax6. Similarly, after
modulation with fate determinants cells expressed
Na + currents to a higher percentage at both time
points after MCAo. After infection with the control
virus cells did not elicit action potentials, but we
were able to detect action potentials after repression of
Olig2 and after overexpression of Pax6. Commonly, we
observed a single action potential during the depolari-
zing pulse, but in some cases more than one action
potential was observed. After Pax6 transduction we
also observed spontaneous current events.
Conclusion: Therapeutic gene transfer via retroviral
vectors into the ischemic lateral striatum resulted in a
significant number of infected cells differentiating into
immature DCX + neurons with Na + currents capable
of generating single action potentials. Our study
demonstrates that resident glia can be re-programmed
toward functional neuronal differentiation following
brain injury in vivo, including specifically synaptic
integration. Our present data provide proof-of-principle
evidence that resident cells proliferating in ischemic
gray matter can be recruited into functional neuronal
differentiation, a crucial first step toward neurorepair.
694. Baicalin can promote neuronal differentiation via modulating Jak/Stat3
and Mash1 pathways in rat neural progenitor cells
J. Shen1,2
1School of Chinese Medicine; 2Research Centre of Heart, Brain, Hormone & Healthy Aging, University of
Hong Kong, Hong Kong, Hong Kong S.A.R.
Objectives: Baicalin, a flavonoid isolated from the
root of Scutellaria baicalensis G, has been proved to
protect neural cells from oxidative injury. Whether
Baicalin could promote neurogenesis is unknown
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yet. In this study, we hypothesized that Baicalin
could stimulate neurogenesis by promoting the
differentiation of neural progenitor cells. To verify
the hypothesis, we investigated the effects of Baica-
lin on the proliferation and differentiation of neural
progenitor cells.
Methods: Neural progenitor cells were prepared
from cortex of embryonic E16 Sprague Dawley rats.
The dissociated cells were seeded at a density
of 1 105cells/ml in a DMEM/F12, replenished
with 2% B27, recombinant human basic fibroblast
growth factor, and epidermal growth factor. The cells
were then cultured with a differentiation medium
contained DMEM/F12 (1:1) replenished 2% B27, 5%
fetal bovine serum for 14 days. Different concentra-
tions of Baicalin (1, 2, 10, 20 mmol/L) were added
into the cultured medium. The newly formed
neurons were identified by co-staining with BrdU,
anti-Tublin b-III (Tuj1), anti-microtubule associated
protein-2 (MAP-2) and 40,60-diamidino-2-phenylin-
dole (DAPI) whereas the formation of glial cells
conformed by co-staining with BrdU and anti-glial
fibrillary acidic protein (GFAP). Fluorescent imaging
was visualized with a fluorescence microscope
system (Leica DMIL). To explore the mechanisms
of Baicalin promoting neuronal differentiation of
neural progenitor cells, we investigated the expres-
sions of p-Stat3 and Mash1 with western blot and
Q-PCR analysis.
Results: Fluorescent studies showed that Baicalin
treatment promoted the neural progenitor cells to
differentiate into neurons but inhibited the formation
of glial cells. Western blot analysis and Q-PCR study
showed that Baicalin dose dependently down-regu-
lated the expression of p-Stat3 but up-regulated
Mash1.
Conclusion: Baicalin could promote neurogenesis
instead of astrogliogenesis of neural progenitor cells,
which is mediated by suppressing Jak/Stat3 pathway
and activating Mash1 gene expression.
Acknowledgement: This study was support by a
Seed Fund for Applied Research, University of Hong
Kong and a Seed Fund for Basic Research, University
of Hong Kong.
809. Dose dependence of isoflurane effects in the adult mouse brain
R. Dallasen, A. Hirko and Y. Xu
Department of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Objective: The general anesthetic isoflurane has been
shown to confer neuroprotection against ischemic
insults by a number of mechanisms including
enhancing hyperpolarization by GABA, increasing
levels of anti-apoptotic proteins, and reducing gluta-
mate release. On the other hand, isoflurane has been
implicated in the generation and accumulation of
A plaques found in Alzheimer’s disease (AD)
and apoptosis in the developing brain. To investigate
mechanisms of isoflurane-induced neurological
change, levels of doublecortin (DCX), a marker of
neurogenesis, c-Fos, a marker of gene activation,
HSP70, a marker of cellular stress, and Bcl-xL, an
anti-apoptotic marker, were compared in adult mice
exposed to various concentrations of isoflurane and
recovered for different lengths of time after exposure.
Method: Adult, male CD-1 mice were exposed to
2 h of 0.6%, 1.3%, or 2% isoflurane anesthesia.
After exposure, mice were given 2 h, 1, 6, or 14 days
to recover. Immunohistochemistry involved staining
for DCX, c-Fos, HSP70, and Bcl-xL. Blue fluores-
cence 4,60-diamidino-2-phenylindole (DAPI) staining
was used to identify cell nuclei. Doublecortin
positive cells were assessed in the dentate gyrus.
Cells positive for c-fos were counted in the cortex,
amygdala, dentate gyrus, and CA1 region of the
hippocampus.
Results: No cells positive for HSP70 or Bcl-xL were
detected in any brain region. There were DCX
positive cells found in the dentate gyrus in all
animals. Whether DCX immunoactivity is signi-
ficantly increased in the anesthetized animals has
yet to be determined. Three-way ANOVA showed
that levels of c-Fos were significantly different
with respect to brain region (P< 0.001), the number
of days after isoflurane exposure (P< 0.001), and
doses of isoflurane (P< 0.001) and that there was
a statistically significant interaction between region,
day, and dose. The overall level of c-Fos expression
in the dentate gyrus was lower than that observed in
any of the other assessed brain regions. In the hip-
pocampal CA1 region, dentate gyrus, and amygdala,
c-fos expression was elevated at the day 0 time
point. In the cortex, c-fos expression on day 0 was
lower in the anesthetized animals than in the control
animals.
Conclusion: Isoflurane anesthesia at sub-clinical and
clinical concentrations caused neither cellular stress,
as measured by HSP70, nor upregulation of anti-
apoptotic genes, as measured by Bcl-xL, in the adult
mouse brain. Isoflurane did affect the expression
of c-Fos, an immediate early gene. The effects of
isoflurane on c-Fos expression are dose dependent,
time dependent, and region dependent. DCX positive
cells found in the dentate gyrus after isoflurane
exposure may indicate induction of neurogenesis
and is worthy of further investigation.
Funded by NIH R37GM049202 and R01NS036124.
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865. Canonical Wnt signaling promotes neurogenesis in the adult murine brain
and reduces apoptotic cell death following focal cerebral ischemia
I. Iordanova1, R. Guzman1, C. Fuerer2, R. Nusse2 and G. Steinberg1
1Department of Neurosurgery, Stanford Stroke Center; 2Department of Developmental Biology, Stanford
University, Stanford, California, USA
Objectives: Canonical Wnt signaling is a conserved
pathway during neural development.1–3 It is essential
for the expansion of the pool of neural progenitors4
and in conferring neuronal identity.5 Wnt signaling is
also indispensable for hippocampal neurogenesis.6
However, the role of Wnt signaling in promoting
neurogenesis within the adult cortex has not been
examined to date. With this work we aimed to
determine the role of Canonical Wnt signaling in the
context of:
(1) adult neurogenesis and
(2) neuroprotection following focal cerebral ische-
mia in mice.
Methods: 100 ng of purified Wnt-3a murine protein
was injected intra-parenchymally into the cortex
and striatum of 12-week old C57/Bl6 male mice. This
was followed by daily administration of 5-bromo-
2-deoxyuridine, BrdU, for one week followed by
immunohistochemical analyses of the cell types
present. Wnt-3a was injected in a similar manner
1 day after middle cerebral artery occlusion (MCAO),
a model of focal cerebral ischemia, followed by BrdU
administration for one week and immunohistochem-
ical analyses, using activated Caspase-3 as a marker
of apoptosis.
Results: When injected into the naı¨ve adult cerebral
cortex and striatum, Wnt-3a promoted de novo
neurogenesis as indicated by the expression of GFAP,
Nestin and Doublecortin. Cells positive for these
markers were situated along the needle track and
were also positive for the mature astroglial cell
marker s-100b. In addition, there was a large pool
of BrdU-positive IBA-1 (microglial) cells situated
close to the neural progenitor cells.
Injecting Wnt-3a after MCAO resulted in a signi-
ficant (6-fold, P< 0.0001) reduction in apoptosis of
the BrdU positive cells within the cortex and the
striatum. This effect was also seen when Wnt-3a was
injected prior to the insult, as well as up to 3 days
after it and persisted at 6 months post-Wnt-3a and
BrdU injection (P< 0.0001).
Conclusions: Canonical Wnt signaling is able to
induce de novo neurogenesis within the adult
murine cortex and striatum, possibly by causing
de-differentiation of mature astrocytes. The role of
the pool of proliferating microglial cells is yet to be
established. Both pre- and post-MCAO injection of
Wnt-3a has a protective effect on the proliferating
cells within the murine cortex and striatum.
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950. Regulation of post ischemic neurogenesis by IGFBP-3
R. Dempsey1 and H. Kalluri2
1Neurological Surgery, University of Wisconsin-Madison; 2University of Wisconsin—Madison, Madison,
Wisconsin, USA
Objectives: Cerebral ischemia enchances the prolifera-
tion of neural progenitor cells in the neurogenic
regions, while upregulating the expression of several
growth factors including, IGF-1 and IGFBP-3 in the
ischemic cortex. Although, IGF-1 increases the prolif-
eration, differentiation and survival of neural progeni-
tor cells, the role of Insulin like growth factor binding
protein-3 (IGFBP-3) in the ischemic brain is not clear.
Methods: To understand the role of IGFBP-3 in
the post ischemic brain, we analyzed the effect of
IGFBP-3 on the IGF-1 mediated proliferation of neu-
ral progenitor cells (NPC) in vitro. We used cultured
neural progenitor cells stimulated by the tested
agents and measured cell proliferation, release of
LDH, incorporation of BrdU and analysis of phos-
pho-Akt and cyclin D1.
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Results: The stimulation of neural progenitor cells
with IGF-1 (50 ng/mL) and FGF2 (20 ng/mL)
enhanched the proliferation of cells. Incubation of
NPC’s with IGFBP-3 (5, 50, 500 ng/mL) reduced the
neurosphere formation only at 500 ng/mL. The
decrease in the neurosphere formation was consis-
tent with the decline in the metabolic activity of
the cells, however IGFBP-3 did not cause cell death
as measured by the release of LDH. Consistent
with these observations, BrdU incorporation
studies established a role for IGFBP-3 in the inhibi-
tion of cell proliferation. Furthermore, immunoblot
analysis demonstrated a decrease in the content of
phospho-Akt and cyclin D1 following incubation
with IGFBP-3, suggesting an inhibitory role for
IGFBP-3 in the IGF-1 mediated proliferation of
cells.
Conclusions: These results together suggest that
IGFBP-3 may play an important role in regulating
post ischemic neurogenesis. These results may have
wider implications for the modulation of brain repair
processes after a variety of insults.
958. Role of IL10 in the neurogenesis of the postnatal SVZ of rodents
E. Pozas, R. Medina and A.M. Planas
Cerebral Ischemia and Neurodegeneration, Institute of Biomedical Research of Barcelona-CSIC-IDIBAPS,
Barcelona, Spain
Objectives: The subventricular zone (SVZ) is the
main neurogenic area in adult brain and after
experimental models of stroke. In normal conditions
the neuroblasts generated in the SVZ migrate
and differentiate into mature interneurons in the
olfactory bulb. After ischemia these neuroblasts
migrate to the lesion areas indicating that adult
neurogenesis can be modulated by pathological
situations.1,2 The specific relevance of the inflamma-
tion associated to CNS pathologies in adult neuro-
genesis is unclear. The first studies showed that
inflammation was detrimental for hippocampal
neurogenesis but the most recent studies indicated
that this context is much more complex.3–5 The
aim of this study is to explore the effects of IL10 in
the differentiation of the neural stem cell (NSC) from
the postnatal SVZ in normal and pathological
situations.
Methods: Several primary cultures (dissociated,
explants, neurospheres) from the postnatal SVZ
were performed from postnatal rats. Cell viability,
proliferation and differentiation were explored
after interleukins treatment. In living cultures cell
viability was measured by IdPr incorporation
and cell proliferation was evaluated by a pulse of
Brdu. Cellular markers (nestin, BIII tubulin, DCX,
and others) were detected by immunofluorescence
on fix cultures. By western blotting the intracellular
pathways activated after interleukin stimulation
were quantified. The studies were mainly focused
in detect the intracellular activation of the Jak/Stat
and MAPK pathways. By RT-PCR the levels of
interleukins and its receptors were analyzed in
cell culture and in in vivo samples. Histological
analyses by immunofluorescence and western
blotting of different cellular markers were evaluated
in neurogenic and non neurogenic areas of the adult
mice.
Results: The postnatal SVZ express high levels of
IL10 receptor. On primary cultures of the SVZ the
exposure to IL10 stimulates the phosphorylation of
STAT 3 as well as ERK1/2 p42-p44 (pErk). The
inhibition of the MAPK pathway abolished the
phosphorylation of Stat3. This observation indicates
that pERK is upstream of STAT3 activation after
IL10 stimulation. Double immunofluorescences
techniques show that pERK is specifically activated
on NSC (Nestin + ). The presence of IL10 on primary
culture of SVZ for several days induces cell death but
have not effects on cell proliferation. In these
cultures Il10 induces changes in the number
of NSC. Preliminary in vivo studies in IL10 KO
mice indicate that the neurogenesis in the SVZ is
altered.
Conclusions: The present results show that NSC
respond to IL10 by activation of ERK 1/2 that induces
the phosphorylation of STAT3, and suggest that this
anti-inflammatory cytokine plays a role in the NSC
differentiation.
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1023. Agmatine enhances neurogenesis of transplanted striatum-derived neural
stem cells in rat brain after experimental stroke
J.Y. Kim1, J.H. Kim2, K.K. Bokara2, Y.M. Nho1, Y.M. Park1, K.A. Park2, W.T. Lee2 and
J.E. Lee1
1Anatomy, BK21 Project for Medical Science, Yonsei University, College of Medicine; 2Anatomy, Yonsei
University, College of Medicine, Seoul, South Korea
Objectives: Transient ischemic attack (TIA) has long
been identified as a risk factor for stroke. Ischemic
injury can cause massive damage from extensive
tissue loss, following the neuronal cells and the
connections that reside there. Agmatine has been
shown to have neuroprotective effect and ability to
modulate differentiation of neural stem cells in
various neuronal disease models.1,2 To better repair
following stroke injury, stroke damaged animal
models were transplanted with striatum-derived
neural progenitor cells and treated agmatine in this
study.
Methods: Using a well established models of focal
cerebral ischemia, male Sprague-Dawley rats
(300±30 g) were subjected to 60 mins middle cere-
bral artery occlusion (MCAO).2 Before transplanta-
tion, striatum-derived neural progenitor stem cells
isolated from E14 fetal ICR mice brain were formed
undifferentiated neurospheres in vitro stained by
BrdU. Animals were transplanted with striatum-
derived neural stem cells at 1 week after MACO
injury and agmatine was co-treated for 7 days to
21 days at the end of occlusion (100 mg/kg, I.P.).
Animals were pretreated by agmatine after the injury
was also transplanted with the neural stem cells at
1 week. To analyze behavior performances, rotarod
test, limb placing test were executed after MCAO. To
investigate whether agmatine involved the differen-
tiation and proliferation of striatum-derived neural
progenitor cells, double immunohistochemical stain-
ing was performed with anti-BrdU antibody for
donor-derived cells, neuronal marker NeuN and
MAP2, migrating neuroblast marker DCX, and astro-
gial marker GFAP antibodies.
Results: Pretreatment of agmatine helped the neural
progenitor cells differentiate to become mature
neural cells at 7 days to 14 days after transplantation.
Histological analysis supported that implantation
of the striatum-derived neural progenitor cells
with agmatine promoted functional recovery, and
decreased infarction cavity and scar tissue formation
compared to lesion-control group. The striatum-
derived neuronal progenitor cells transplanted
groups with agmatine regained approximately nor-
mal reflex in response to the stimuli within 3 weeks.
In contrast, lesion-control group regained only about
50% of reflex response for 4 weeks.
Conclusions: Here, we show that agmatine which
has been known as a neuromodulator in the brain
enhances neurogenesis of striatum-derived neural
stem cells. These results displayed that cell derived
from neural progenitor cells exhibited the differen-
tiation of functional neurons and synapse formation
by agmatine treatment.
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